SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001599298-24-000068
Filing Date
2024-04-15
Accepted
2024-04-15 09:19:13
Documents
1
Period of Report
2024-04-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1713187142.html 3  
1 FORM 3 wk-form3_1713187142.xml 3 1662
  Complete submission text file 0001599298-24-000068.txt   3296
Mailing Address 9885 TOWNE CENTRE DRIVE SAN DIEGO CA 92121
Business Address
Ronaghi Mostafa (Reporting) CIK: 0001441876 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36866 | Film No.: 24843291

Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 650-460-8308
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)